glp-1 physiology and the kidney: from to pharmacology and outcomes in diabetes Physiological vs pharmacological actions of

Non-Diabetic PAD Patients on GLP-1RAs Show Reduced Risk of Serious Cardiovascular Outcomes Compared to Those Without GLP-1RAs PAD is a condition where the peripheral arteries that carry blood away from the heart to other parts of the body become narrowed or blocked, reducing blood flow to the limbs, often in the legs

These medications work differently but ultimately aim to control high blood sugar levels in patients diagnosed with Type 2 Diabetes

They've also often lost confidence in the idea that anything will work, which affects how they engage with later treatment

Baral KC et al

Savic D, Hodson L, Neubauer S, Pavlides M

18 However, its rapid hydrolysis by intestinal lactase and SGLT1 inhibition causing diarrhea limited its clinical use